Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors
Ohad Oren, Eric H. Yang, Julian R. Molina, Kent R. Bailey, Roger S. Blumenthal, Stephen L. Kopecky
Topics & Concepts
MedicineHazard ratioInternal medicineProportional hazards modelCancerLung cancerHeart failureAdverse effectConfidence intervalCancer Immunotherapy and BiomarkersChemotherapy-induced cardiotoxicity and mitigationPARP inhibition in cancer therapy